Nanowired Delivery of Drugs and Antibodies for Neuroprotection in Brain Diseases with Co-morbidity Factors, Volume 171 is a book that highlights the latest advances in the field of neuroprotection in brain diseases with co-morbidity factors. Written by Hari Shanker Sharma, a renowned expert in the field, this book is a valuable resource for researchers, scientists, and clinicians working in neuroscience.

The book covers a wide range of topics, including neurodegenerative diseases, stress-induced exacerbation of Alzheimer’s disease, Parkinson’s disease with emotional stress, and the efficacy of invasive and non-invasive methods for the treatment of Parkinson’s disease. Each chapter presents the latest research and developments in the field, providing readers with valuable insights and new perspectives.

One of the key highlights of this book is the focus on nanowired delivery of drugs and antibodies for neuroprotection. Nanowires are nanoscale structures that can be used to deliver drugs and antibodies directly to the brain, bypassing the blood-brain barrier. This approach has shown promising results in the treatment of various brain diseases, and the book explores its potential in detail.

The book also discusses the role of co-administration of different substances for neuroprotection. For example, the co-administration of nanowired cerebrolysin and amyloid beta peptide antibodies with a serotonin 5-HT6 receptor antagonist has shown to thwart the stress-induced exacerbation of Alzheimer’s disease brain pathology. Similarly, the co-administration of DL-3-n-butylphthalide and neprilysin has shown neuroprotective effects in Alzheimer’s disease associated with brain injury.

Another interesting topic discussed in the book is the impact of sleep deprivation on Parkinson’s disease pathophysiology. The co-administration of nanowired cerebrolysin and serotonin-3 receptor antagonist ondansetron has been shown to attenuate the sleep deprivation-induced exacerbation of Parkinson’s disease pathophysiology. These findings suggest the potential of nanowired delivery in treating sleep-related brain disorders.

The book also delves into the effects of stress on brain diseases. Stress has been found to worsen the symptoms and progression of various brain diseases, and the book explores the underlying mechanisms and potential interventions. The role of nanowired delivery of multimodal drugs and antibodies, such as cerebrolysin and monoclonal 5-HT antibodies, in mitigating the effects of stress on the brain is discussed in detail.

Overall, Nanowired Delivery of Drugs and Antibodies for Neuroprotection in Brain Diseases with Co-morbidity Factors, Volume 171 is a comprehensive and informative book that presents the latest research and developments in the field of neuroprotection. By focusing on nanowired delivery and the co-administration of different substances, the book provides valuable insights into potential interventions for brain diseases with co-morbidity factors.

If you are a researcher, scientist, or clinician working in the field of neuroscience, this book is a must-have resource. It offers a comprehensive overview of the latest research and developments in the field, allowing you to stay up-to-date with the advancements and potential interventions for neuroprotection in brain diseases.

Order your copy of Nanowired Delivery of Drugs and Antibodies for Neuroprotection in Brain Diseases with Co-morbidity Factors, Volume 171 today and delve into the exciting world of nanowired delivery and neuroprotection!